Arrayomics Inc. developing a particle-based assay platform, Addressable Multiplex Platform (AMP), for both genomic and proteomic analyses. This technology combines the high sensitivity and efficient workflow of particle-based systems (liquid arrays) and the efficient and versatile detection methods available for microarrays. Addressable Multiplex Platform (AMP) provides laboratories with a universal all in one platform